Investment archive

Investment feed — page 139

Back to latest investments

Bending Spoons completed acquisition of Meetup

Bending Spoons completed acquisition of Meetup

Meetup helps people organize and discover interest-based groups and events. Organizers use it to build communities, while members find activities and gatherings. Bending Spoons completed its purchase of Meetup’s parent on January 23, 2024. Deal value: Individual price not separately disclosed in reviewed filing; part of $280.7M three-deal group.

Pliant discloses €8M Series A extension, €33M cumulative

Pliant discloses €8M Series A extension, €33M cumulative

Pliant announced its Series A had grown from €25M to €33M with an additional €8M; the €33M represents cumulative Series A commitments, not new incremental equity. The separately announced €100M debt facility is excluded.

Unnatural Products announces $32M Series A co-led by Merck GHI and ARTIS Ventures

Unnatural Products announces $32M Series A co-led by Merck GHI and ARTIS Ventures

Company-issued December 19, 2023 announcement of a $32M Series A financing co-led by Merck Global Health Innovation Fund and ARTIS Ventures. Proceeds support synthetic macrocyclic peptide discovery. Exact legal close day and valuation undisclosed. This historical equity is separate from the 2026 Series B and argenx's proposed acquisition.

Delphina announced $7.5M seed led by Costanoa and Radical Ventures in 2023

Delphina announced $7.5M seed led by Costanoa and Radical Ventures in 2023

Delphina's original December 13, 2023 issuer release confirmed a $7.5M seed co-led by Costanoa Ventures and Radical Ventures, with angel participation. This is a distinct earlier financing, not part of the new November 2026 $7.5M proceeds. Valuation and separate legal close date undisclosed.

Group 11 announces $20M secondary sale of Fund II interests

Group 11 announces $20M secondary sale of Fund II interests

StepStone and Industry Ventures purchased 12% of Fund II interests for $20M. This fund-level liquidity transaction is not new startup financing or a new venture fund close.

Saviu II reports €12M first close in November 2023

Saviu II reports €12M first close in November 2023

Issuer press release confirms €12M cumulative first-close commitments; not a new €12M on top of subsequent close stages.

AI21 Labs completes $208M Series C after $53M extension

AI21 Labs completes $208M Series C after $53M extension

AI21 announced its $208M Series C total on November 21, 2023, comprising the previously announced $155M initial close and a $53M extension. This is one Series C, not separate $208M plus $155M rounds. Israeli reporting later established that a widely reported $300M 2025 Series D never closed.

T-Therapeutics announces $59M initial Series A

T-Therapeutics announces $59M initial Series A

Initial tranche; later expanded to cumulative $91M Series A.

Layer Health announces $4M seed backed by GV, General Catalyst and Inception Health

Layer Health announces $4M seed backed by GV, General Catalyst and Inception Health

Layer Health disclosed $4M early financing on November 14, 2023. Original company announcement names GV, General Catalyst and Inception Health without an individual lead, and the seed is separate from the later $21M March 2025 Series A.

VectorY Therapeutics closed €129M Series A in November 2023

VectorY Therapeutics closed €129M Series A in November 2023

Historical 2023 Series A, co-led by EQT Life Sciences and Forbion Growth Opportunities Fund; distinct from the November 2026 mixed financing package. The company issued its announcement November 13, 2023.

Craft closes $608M Growth II

Craft closes $608M Growth II

Craft announced $608M for Growth II on November 9, 2023, alongside a separate $712M Ventures IV.

Craft closes $712M Ventures IV

Craft closes $712M Ventures IV

Craft announced $712M for Ventures IV on November 9, 2023, alongside a separate $608M Growth II.